Katarina Ageborg net worth and biography

Katarina Ageborg Biography and Net Worth

EVP of Sustainability of AstraZeneca

Katarina was appointed Executive Vice-President, Sustainability in 2017 and has been a member of SET since 2011. She has overall responsibility for the delivery, design and implementation of the Company’s sustainability programme, covering three priority areas: access to healthcare; environmental protection; and ethics and transparency. She leads the Global Sustainability function, including teams focusing on Compliance, and Safety, Health and Environment. Katarina was also appointed President of AstraZeneca AB (Sweden) in 2018, and her role is focused on strengthening corporate reputation and relations by actively representing the Company in the Swedish business and academic community. Prior to her current roles, Katarina led the Global Intellectual Property function from 2008 to 2011, during which time she streamlined the organisation and launched a new patent filing strategy before taking the role as Chief Compliance Officer. Katarina holds a Master of Law Degree from Uppsala University School of Law in Sweden and ran her own law firm before joining AstraZeneca in 1998.

How do I contact Katarina Ageborg?: The corporate mailing address for Ms. Ageborg and other AstraZeneca executives is 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE X0, CB2 0AA. AstraZeneca can also be reached via phone at 442037495000 and via email at [email protected]. Learn More on Katarina Ageborg's contact information.
Has Katarina Ageborg been buying or selling shares of AstraZeneca?: Katarina Ageborg has not been actively trading shares of AstraZeneca within the last three months. Learn More on Katarina Ageborg's trading history.
Who are AstraZeneca's active insiders?: AstraZeneca's insider roster includes Katarina Ageborg (EVP of Sustainability), Pam Cheng (EVP of Operations & Information Technology and Member of External Sustainability Advisory Board ), Marc Dunoyer (CEO of Alexion & Chief Strategy Officer ), Menelas Pangalos (EVP ), Aradhana Sarin (CFO & Exec. Director ), and Pascal Soriot (Executive Director and Chief Executive Officer ). Learn More on AstraZeneca's active insiders.

Katarina Ageborg Insider Trading History at AstraZeneca

Katarina Ageborg Buying and Selling Activity at AstraZeneca

AstraZeneca Company Overview

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Today's Range

Now: $66.04

$65.77

$66.41

50 Day Range

MA: $68.09

$63.20

$78.26

2 Week Range

Now: $66.04

$60.47

$87.68

Volume

2,970,112 shs

Average Volume

5,323,847 shs

Market Capitalization

$204.77 billion

P/E Ratio

31.60

Dividend Yield

1.50%

Beta

0.45

BITCOIN

From Awesomely, LLC | Ad

Did you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this...

Watch this short video